Socialised Medicine: Life-Prolonging Drug Deemed 'Too Expensive' for NHS Breast Cancer Patients

Breast cancer patients in England will not be able to avail of a life-prolonging drug after the country’s socialised healthcare system deemed it ‘too expensive’.